Health ❯ Healthcare ❯ Medical Research

Neurology

Alzheimer's Disease Dementia Parkinson's Disease Epilepsy Migraine Treatment Stroke Multiple Sclerosis Biomarkers Dementia Awareness Tauopathies

Migraine CGRP Drugs Tied to Lower Glaucoma Risk in Neurology Study

Researchers urge caution pending confirmatory studies.

Mayo Clinic Study Finds Autism Far More Common in Children With Epilepsy

Common Blood Test Marker Linked to Higher Future Dementia Risk, Large Study Finds

Major Review Says New Alzheimer’s Antibodies Offer No Meaningful Benefit

Blood Test Detects Alzheimer’s Risk Years Before PET Scans

Meta-Analysis Finds No Link Between Hormonal Birth Control and Idiopathic Intracranial Hypertension

CSF Enzyme Marker Distinguishes Parkinson’s and Lewy Body Dementia From Alzheimer’s

Dual Blood Markers Sharpen Alzheimer’s Diagnosis by Cutting False Positives

PrimeC Shows Safety and Potential Benefit in ALS Phase 2b as FDA Authorizes Phase 3

Blood Test Using p‑Tau217 Predicts Dementia Risk in Women Up to 25 Years Before Symptoms

Early Alzheimer’s Markers Identified in Peripheral Retina in Mouse Study

Blood ‘Clock’ Predicts Alzheimer’s Symptom Onset Within 3–4 Years

Anti-Seizure Drug Levetiracetam Blocks Early Alzheimer’s Protein Production, Study Finds

Finger‑Prick Alzheimer’s Blood Test Moves Forward in International Trial With 883 Enrolled

Finger-Prick Blood Spot Test Detects Alzheimer’s Biomarkers With 86% Accuracy

Finger-Prick Dried Blood Test Flags Alzheimer’s Biomarkers in European Study

Largest Blood-Test Study Finds Alzheimer’s Changes Common in Older Adults

American Headache Society Elevates Nerve Blocks, IV Prochlorperazine to Must‑Offer ED Migraine Care

Novo Defends Semaglutide Alzheimer’s Strategy After Phase 3 Miss

Shingles Vaccine, Viagra and Riluzole Topped Exeter-Led List for Potential Alzheimer’s Repurposing